Wall Street analysts predict that Dextera Surgical Inc (NASDAQ:DXTR) will post earnings of ($0.06) per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Dextera Surgical’s earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.05). Dextera Surgical posted earnings of ($0.41) per share during the same quarter last year, which suggests a positive year over year growth rate of 85.4%. The business is expected to report its next quarterly earnings results on Tuesday, February 6th.
According to Zacks, analysts expect that Dextera Surgical will report full year earnings of ($0.25) per share for the current financial year, with EPS estimates ranging from ($0.28) to ($0.21). For the next fiscal year, analysts anticipate that the company will report earnings of ($0.21) per share, with EPS estimates ranging from ($0.22) to ($0.20). Zacks’ EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Dextera Surgical.
Dextera Surgical (NASDAQ:DXTR) last issued its quarterly earnings data on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.02). The company had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $0.62 million.
Shares of Dextera Surgical (DXTR) traded down $0.01 during mid-day trading on Thursday, reaching $0.13. The company had a trading volume of 1,267,300 shares, compared to its average volume of 3,557,199. Dextera Surgical has a 52-week low of $0.11 and a 52-week high of $2.33.
A hedge fund recently raised its stake in Dextera Surgical stock. Virtu KCG Holdings LLC lifted its stake in shares of Dextera Surgical Inc (NASDAQ:DXTR) by 1,380.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 369,918 shares of the medical instruments supplier’s stock after purchasing an additional 344,933 shares during the quarter. Virtu KCG Holdings LLC owned about 4.14% of Dextera Surgical worth $111,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 4.49% of the company’s stock.
About Dextera Surgical
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Dextera Surgical Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Dextera Surgical Inc and related companies.